Quick answer: C-peptide is released when the pancreas makes insulin and can help assess the body’s own insulin production in selected clinical situations. It is not a routine diabetes screening test. Interpretation needs the glucose level, sampling conditions and kidney function. Blood testing commonly uses immunoassay; QXL must confirm its method, collection requirements and report time before an appointment in Bengaluru.
Also known as: C peptide, connecting peptide, endogenous insulin secretion
What is the C-Peptide test used for?#
- Clarifying diabetes classification when the clinical picture remains ambiguous.
- Specialist evaluation of documented hypoglycaemia with glucose, insulin and other indicated investigations.
- Selected assessment of residual insulin secretion or follow-up after pancreatic intervention.
Conditions it helps investigate: Insulin secretion disorders
What does the test measure?#
- C-peptide: Marker of endogenous insulin secretion, interpreted with concurrent glucose and clinical context.
- Concurrent glucose, if ordered: Shows whether insulin secretion is appropriate for the prevailing glucose; confirm separate inclusion.
How is it tested?#
Antibody-based immunoassay commonly measures circulating C-peptide. The assay does not measure injected insulin itself. Platform calibration, cross-reactivity and sample requirements vary; QXL must confirm the actual assay and whether concurrent glucose is included.
Sample and preparation#
Specimen: Venous blood; serum or plasma suitability must be confirmed for the actual QXL assay.
- The clinician must specify fasting, random or stimulated sampling; these are different protocols.
- Arrange simultaneous glucose when requested and document the last meal and diabetes medicine timing.
- Do not withhold insulin or deliberately induce a low glucose level at home; supervised hypoglycaemia testing requires a clinical setting.
| Specimen detail | What to confirm |
|---|---|
| Volume | Confirm minimum and paediatric volume with QXL test master. |
| Container | Use the collection tube or container specified by the actual QXL test SOP. |
| Stability | Confirm separation deadline, validated transport temperature, cold-chain and stability window with QXL. |
| Rejection | QXL must confirm identification, specimen quality, quantity and transport acceptance criteria. |
How are the results interpreted?#
- A result may indicate endogenous secretion only in relation to the glucose stimulus and clinical setting.
- A lower result during hyperglycaemia may support insulin deficiency; it does not alone establish a diabetes subtype.
- Kidney impairment can increase circulating C-peptide and complicate interpretation.
Reference interval: Use the method, units and context-specific interval or decision limits on the actual laboratory report; no universal numeric normal range is substituted.
What are the limitations?#
- Recent food, current glucose, duration of diabetes and renal function influence the result.
- Assays differ; results and cut-offs from separate platforms may not be directly interchangeable.
- Insulin-secretagogue exposure can cause an endogenous secretion pattern; C-peptide alone cannot identify its cause.
How does it compare with other tests?#
- C-peptide reflects endogenous secretion, whereas insulin assays may detect endogenous insulin and some injected analogues depending on the method.
- Glucose and HbA1c remain established tools for diabetes diagnosis; C-peptide addresses a different question.
Notes for referring clinicians#
State the clinical question, relevant treatment and specimen timing. Discuss unexpected or discordant results with the laboratory before changing management.
Price, report time and home collection#
- Price: Request the current QXL quote, included components and any collection charges.
- Report time: Confirm test-specific QXL reporting time, its starting point, working-day conditions and any referral transit before collection.
- Home collection: Ask QXL to confirm Bengaluru pincode eligibility, test suitability, collection timing and whether the visit is free.
- Processing: QXL verification pending: performing laboratory, platform and in-house versus referral status.
- Report review: Appropriately qualified laboratory authorisation is required. Ask QXL whether a separate report-discussion appointment is available. This content has not received medical sign-off.
Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.
Frequently asked questions#
Does C-peptide measure the insulin I inject?#
No. Injected insulin does not contain C-peptide; the test assesses secretion from your own pancreas.
Can this diagnose diabetes by itself?#
No. Diabetes diagnosis uses validated glucose or HbA1c criteria in the appropriate clinical pathway.
Should I fast for C-peptide?#
Your clinician must specify a fasting, random or stimulated protocol. Do not substitute one protocol for another.
Why is glucose collected at the same time?#
C-peptide must be interpreted against the prevailing glucose to assess whether insulin secretion is appropriate.
Can kidney disease alter C-peptide?#
Yes. Reduced renal clearance can raise the level and limit interpretation.
Should I stop insulin before collection?#
Do not stop insulin yourself. Obtain a safe, individual medicine plan from your treating clinician.
Does a low value prove type 1 diabetes?#
No. Disease duration, glucose, kidney function and other clinical or antibody findings may be needed.
How do I confirm QXL collection and reporting?#
Ask QXL for the correct protocol, specimen instructions, concurrent glucose inclusion, current quote and reporting time.
Related test guides#
Sources#
- Tietz ninth edition, PDF pages 1734–1739: appropriate C-peptide use, endogenous secretion and assay variation.
- A Manual of Laboratory and Diagnostic Tests ninth edition, PDF pages 364–365: C-peptide and concurrent glucose context. Current laboratory SOP must govern collection.
Educational information only; not a diagnosis or a substitute for a doctor’s advice.
Medical & Laboratory Disclaimer
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Dr. Shantakumar Muruda
MD (Biochemistry), Founder & CEO
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

